Benzofurocaine: effects on experimental periodontitis, anti-diabetic activity and molecular mechanisms of action
Introduction: A promising compound for the treatment of inflammatory periodontal diseases is benzofuracaine (BFC). BFC has pronounced anti-inflammatory, analgesic, reparative, hypoglycemic and other effects. Objective: To assess the influence of benzofuracaine on experim...
Main Authors: | Pavel A. Galenko-Yaroshevsky, Viktor L. Popkov, Karine A. Bedrosova, Leonid A. Faustov, Galina V. Sukoyan, Andrej V. Zadorozhny, Ol’ga N. Gulevskaya, Aleksandr V. Uvarov, Valeriya S. Dobrodomova |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2019-03-01
|
Series: | Research Results in Pharmacology |
Online Access: | https://rrpharmacology.pensoft.net/article/33100/download/pdf/ |
Similar Items
-
Benzofurokain as a corrector of regenerative processes in the gums in experimental periodontitis treatment
by: K. A. Bedrosova, et al.
Published: (2016-02-01) -
Effect of benzofurocainum on blood microcirculation in the attached gum in conditions of sound parodentium and experimental periodontitis
by: K. A. Bedrosova, et al.
Published: (2016-04-01) -
Mafusol and its combination with REXOD as correctors of reduced blood circulation in the skin associated with normoglycemia or diabetes mellitus complicated by exogenous hypercholesterolemia
by: Olga N. Gulevskaya, et al.
Published: (2021-05-01) -
Impact of new Rexod® injection form on blood microcirculation in rat skin
by: K. V. Tseluyko, et al.
Published: (2020-10-01) -
DEVELOPMENT PERSPECTIVES OF NEW GENERATION MEDICATIONS BASED ON THE REDOX SYSTEM REGULATORS
by: Svetlana Shahmardanova, et al.
Published: (2016-12-01)